Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • Have taken opinion for...

Have taken opinion for all formulation of drug Nimesulide for vulture conservation: Health Ministry to Delhi HC

Ruchika SharmaWritten by Ruchika Sharma Published On 2023-11-08T15:30:48+05:30  |  Updated On 9 Nov 2023 5:46 PM IST
Delhi HC Orders Arbitration in Medikabazaar Board Dispute, Tiwari Challenges Termination
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

The plea sought direction to the respondents to promote the use of Meloxicam (Salt Formula) for veterinary use as the same poses no risk to vultures and also sought direction to constitute a monitoring committee to check and supervise that toxic NSAIDs are not in use in the open market.

New Delhi: The Delhi High Court has been informed by the Ministry of Health and Family Welfare that it has issued a letter to the Ministry of Fisheries, Animal Husbandry, and Dairying to take an opinion for all formulation of drug Nimesulide for vulture conservation.

The Ministry of Health and Family Welfare in its reply filed in the Delhi High Court stated that the Central Drugs Standard Control Organisation (CDSCO) has issued a letter dated September 13 to the Commissioner of the Department of Animal Husbandry and Dairying (Ministry of Fisheries, Animal Husbandry and Dairying) to take opinion for all
formulation of drug
Nimesulide for vulture conservation and a reply is awaited from the said department.
According to the reply copy, as per minutes of the 89th Drug Technical Advisory Board (DTAB) held on May 10, a recommendation was made to constitute a sub-committee to examine a list of such drugs that affect animal health or the environment. In this regard, the answering respondent is in the process of constitution of the sub-committee.
The reply of the Health Ministry has been filed in an ongoing matter, seeking to create an effective mechanism for safety testing of the drugs on wild scavenging birds before launching New NSAIDs (Non-steroidal anti-inflammatory drugs) in the open market.
Earlier, the Ministry of Health and Family filed an affidavit in Delhi High Court informing that they have recommended banning of two drugs namely Aceclofenac and Ketoprofen as the same are toxic for Vultures.
On the last date, the Delhi High Court had asked the Union of India to furnish the reasons as to why the drug 'Nimesulide' has not been banned, and deliberations undertaken in this regard.
The court in an earlier hearing in this matter noted that petitioner Gaurav Kumar Bansal stated that his grievance arose in respect of four non-steroidal anti-inflammatory drugs (NSAID) used in veterinary care, which are admittedly toxic to Vultures, three of which already stand banned, namely, Acelofenac, Ketoprofen, Diclofenac whereas the sole remaining drug, '
Nimesulide
' continues to be sold in the market.
The plea was filed by Advocate Gaurav Kumar Bansal sought the banning of Toxic Drugs that are harmful to Vultures. He submitted that the Centre has not taken any steps to ban the other toxic drug (Nimesulide) which is equally responsible for the sharp decline of the population of Vultures in India.
The Delhi High Court has directed the Union of India to apprise the court about the steps taken by them to ban the other toxic drug (
Nimesulide
) on the next date of hearing.
Bansal, in his petition, has stated that because of the toxic drugs (NSAIDs like Aceclofenac, Ketoprofen, Nimuslide, Diclofenac etc), the population of the vultures in the country has declined very sharply.
The Public Interest Litigation (PIL) has also sought direction to create an effective mechanism for safety testing of the drugs on wild scavenging birds before launching New NSAIDs (Non-steroidal anti-inflammatory drugs) in the open market.
The plea sought direction to the respondents to promote the use of Meloxicam (Salt Formula) for veterinary use as the same poses no risk to vultures and also sought direction to constitute a monitoring committee to check and supervise that toxic NSAIDs are not in use in the open market.
The plea seeks court intervention regarding the protection and conservation of vultures in India as they are now listed as critically endangered by the IUCN and are also placed in Schedule -1 of the Indian Wildlife Protection Act - 1972 which is the highest category of endangerment.
The plea further submitted that nine Species of vultures are recorded from India of which five belong to the genus Gyps. Three Gyps Vultures, namely Oriental White-backed vulture, Long Billed vulture and Slender Billed vulture are residents, and the remaining two- Eurasian Griffon and Himalayan Griffon are largely winter species and a small population breeds in the Himalayas.
The plea further stated that the cause of the population decline of vultures in India is the veterinary use of NSAIDS in livestock. NSAIDs have analgesic, anti-arthritic and antipyretic properties and as such are used to treat a wide variety of common ailments in Domestic ugulates (cows, sheep, goats, pigs, deer), said the plea.
The petition submitted that there are many NSAIDs that are available in the market and are used in veterinary for Domestic ugulates. The plea also submitted that vultures are exposed to toxic levels of NSAIDs when they feed on carcasses of livestock that have died within a few days of treatment, and which contain residues of the said NSAIDs.
The plea submitted that vultures are an integral part of our ecosystem as they play a major role in cleaning dead carcasses in a short period of time.
According to the petition, the diclofenac drug has been used in India extensively in the veterinary for domestic ungulates and was responsible for the sharp decline in the vulture population in the country.
In the year 2006, the central government banned diclofenac for veterinary use throughout the country by way of invoking its power under Section 26A of the Drugs and Cosmetic Act.
However, despite the diclofenac ban in 2006, things have not improved much as the illegal sale of human diclofenac for veterinary use is still rampant in India as well as the increased use of toxic NSAIDs like Aceclofenac and Ketoprofen,
Nimesulide
and other drugs.
It is clear that the banning of diclofenac alone is of no use and if respondents are not going to ban other toxic NSAIDs like Aceclofenac, Nimesulide and Ketoprofen, the plea read.
Read also: Indian pharma cos have become reliable, affordable suppliers of high quality drugs, says Shri Bhagwant Khuba
Delhi High CourtNimesulideCDSCOAceclofenacKetoprofen
Source : ANI
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok